Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Swift Run Capital Unveils Its Top Picks Heading Into Q2

Among the hedge funds that we track, 38 had an aggregate investment of $815.80 million in Colony Capital Inc (NYSE:CLNY) at the end of the fourth quarter. Brian Jackelow‘s SAB Capital Management and Emanuel J. Friedman’s EJF Capital were two other investment firms with exposure to the company.

Swift Run initiated a stake in the operator of kidney dialysis centers, DaVita HealthCare Partners Inc (NYSE:DVA) in the last quarter of 2013 with 35,200 shares. After increments in the following quarters, the stake surged to about 179,600 shares valued at $14.59 million at the end of March. The holding represents 6.36% of the fund’s equity portfolio. DaVita HealthCare Partners Inc (NYSE:DVA)’s stock is up by about 7.09% year to date. The $17.83 billion healthcare company was recently upgraded to ‘Outperform’ by Baird with a $95 price target, which is about 15% above the current trading levels. Legendary investor, Warren Buffett‘s Berkshire Hathaway is the largest shareholder of the company and held 38.57 million shares according to its last filing.

Huntsman Corporation (NYSE:HUN)‘s holding received a major bump as an additional 172,856 shares of the $5.58 billion company were acquired during the January-March quarter. The current stake contains slightly over 626,600 shares valued at $13.89 million. In its financial results for the first quarter, Huntsman Corporation (NYSE:HUN) delivered an EPS of $0.40, which was $0.12 higher than what analysts expected. Quarterly revenues of $2.59 billion, however, came in $260 million lighter than the estimates. Dinakar Singh’s TPG-Axon Management LP held 8.37 million shares of Huntsman Corporation (NYSE:HUN) at the end of 2014.

Microsoft Corporation (NASDAQ:MSFT) and Exxon Mobil Corporation (NYSE:XOM) represented Swift Run’s holdings in mega-caps. Mullen added some 2,550 shares of Microsoft Corporation (NASDAQ:MSFT) to his fund’s portfolio during the first quarter and took his total exposure in the technology giant to 26,290 shares valued at $1.07 million. The company’s turnaround in the recent quarter as compared to the previous one has surprised analysts. Not only the cloud business delivered impressive results, but revenues from Windows also looked to be in better shape than expected. Jeffrey Ubben’s ValueAct Capital held about 74.24 million shares of Microsoft Corporation (NASDAQ:MSFT)  at the end of last year.

Moving on to Exxon Mobil Corporation (NYSE:XOM), in which a position was initiated by Swift Run in the first quarter with some 7,098 shares valued at $603,000. Exxon Mobil Corporation (NYSE:XOM) has a 40% stake in an offshore project in Angola and it has been recently announced that production had started at the Kizomba Satellites. A total of 190 million barrels of oil are expected from the project with peak production of 70,000 bbl/day. Donald Yacktman’s Yacktman Asset Management reduced its stake in Exxon Mobil Corporation (NYSE:XOM) by 50% during the fourth quarter to 7.01 million shares valued at $648.25 million.

Disclosure: None

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.